Exosmart™ is a CE-MDR certified Class IIa medical device that revolutionizes regenerative medicine through patented ultrafiltration technology. Using a 15 kDa molecular weight cutoff membrane, exosmart™ transforms 30mL of plasma (from 60mL blood) into 6-7mL of concentrated therapeutic product containing up to 30 trillion exosomes per milliliter—136x higher than reference standards.

Our MISEV2023-compliant validation demonstrates exceptional purity with 93.2% CD9 positive markers and 47% PDGF-bb growth factor increase. The concentrated product contains exosomes (30-150nm), platelets (70-95% recovery), growth factors (VEGF, TGF-β, FGF), cytokines, and plasma proteins—all working synergistically to modulate inflammation, stimulate stem cells, promote angiogenesis, and accelerate tissue regeneration across multiple clinical applications.

With proven safety (zero adverse events in clinical trials) and 100% processing success rate, exosmart™ transforms routine procedures into advanced regenerative therapy. From orthopedics to aesthetics, wound care to surgical applications—deliver standardized, reproducible results that often achieve in one session what traditional approaches require multiple treatments to accomplish.